A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy.
about
Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathyPharmacological interventions for treating heart failure in patients with Chagas cardiomyopathyPharmacological interventions for treating heart failure in patients with Chagas cardiomyopathyTreatment of Chagas cardiomyopathyThe Epidemiology, Clinical Manifestations, and Management of Chagas Heart DiseaseHigh throughput screening for anti-Trypanosoma cruzi drug discoveryCausal inference regarding infectious aetiology of chronic conditions: a systematic review.Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.Carvedilol enhances the antioxidant effect of vitamins E and C in chronic Chagas heart diseaseLow doses of simvastatin therapy ameliorate cardiac inflammatory remodeling in Trypanosoma cruzi-infected dogs.Health-related quality of life in patients with Chagas disease: a review of the evidence.Chagas heart disease: report on recent developments.The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy.Enalapril in Combination with Benznidazole Reduces Cardiac Inflammation and Creatine Kinases in Mice Chronically Infected with Trypanosoma cruzi.Autonomic dysfunction and beta blocker therapy in Chagas heart disease.Developments in the management of Chagas cardiomyopathy.An update on the management of Chagas cardiomyopathy.Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathyInsights into the clinical and functional significance of cardiac autonomic dysfunction in Chagas disease.Diagnosis and management of Chagas disease and cardiomyopathy.Epidemiology of Chagas disease in Europe: many calculations, little knowledge.The metabogenic role of iron in chronic chagasic cardiac failure.Morbidity and prognostic factors in chronic chagasic cardiopathy.Inhibition of NFE2L2-Antioxidant Response Element Pathway by Mitochondrial Reactive Oxygen Species Contributes to Development of Cardiomyopathy and Left Ventricular Dysfunction in Chagas Disease.An Infrequent Cause of Apical Ventricular Aneurysm in the United States.Cardiac autonomic control mechanisms in the pathogenesis of chagas' heart disease.Potential Role of Carvedilol in the Cardiac Immune Response Induced by Experimental Infection with Trypanosoma cruziImmunopharmacological approach of carvedilol in chronic Chagas heart disease.Enalapril prevents cardiac immune-mediated damage and exerts anti-Trypanosoma cruzi activity during acute phase of experimental Chagas disease.Predictors of all-cause 1-year mortality in implantable cardioverter defibrillator patients with chronic Chagas' cardiomyopathy.Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease.Challenges for improving quality of life in Chagas disease.The β-blocker carvedilol and the benznidazole modulate the cardiac immune response in the acute infection induced by Colombian strain of the Trypanosoma cruziCardiac resynchronization therapy for patients with chronic systolic heart failure secondary to Chagas cardiomyopathy in the 21st century
P2860
Q24202908-8EADF677-BB88-4733-A350-869E816A1090Q24235451-E3122D37-FD2A-4B45-92ED-AEDE97D05259Q26471149-0F204027-06E7-422F-8E3E-9154AF8ABF85Q26829616-DEDC1325-EE5E-434D-8697-E45349B0F33BQ28084634-404FE9E2-EA7D-4C80-A927-F5BBD77B624DQ28542489-521C0E19-2BBE-4ECB-870D-ACD524F56E59Q31126057-94A87405-E9F5-4D3D-B155-5CC93B975131Q33604028-FECBCC92-725E-463D-AEBD-F3F7D234A57BQ33773325-FC74DC32-8A71-4922-A5EA-DC207B4118DFQ34531351-3915CB09-0C2F-4248-A565-F80E972961BDQ35636372-6CB54F04-8461-4EF6-BEBA-47D6EB8C6424Q35745413-EA1AA39D-097D-4AF6-9EE2-E069E42289E8Q36223002-1187D737-385E-49A8-B24A-400A4F8CAB71Q36436221-8FB06E36-B7E6-4B0E-AE6B-60C992E1D162Q36644792-A1B21690-BD32-4B27-BB44-06B4190B2797Q36737035-D2E2D15B-ACE3-4CB4-973B-C1CE6C10927CQ36901974-AB1C73B5-961A-4A51-BAA7-E748497A02DAQ37781700-5D322578-1D32-46DE-87FB-17385BB6A5F0Q38005593-896CB3D4-08DD-42F9-9C6D-BDEAF3AE861BQ38030830-6AF21A94-59B5-4C90-A148-229F7848AED1Q38132635-7A1CA622-1698-4350-A661-4A70C331EBF8Q39253448-60A5F8C2-0881-443B-BA81-256BD963ED82Q39403291-2CA6213D-7DC6-4B0E-A823-3349CDFF8E2BQ40354504-B737BA91-6FAE-4CF9-9986-E06828E02ED2Q40957106-438B34C0-D83D-4524-8ECD-B5814128F252Q41822801-5E43B55E-A6C8-4B0B-8BA0-1D1BDD5124FDQ42102813-47902355-C493-4640-894C-3B3EEE743695Q42956832-D2A04F4B-7304-45F0-90A8-E6CFC15B6C5EQ43096490-6D3D88CB-21B4-4903-86FD-7C4C6A5CC56FQ44953687-D574495B-A380-4EC4-9C0C-653FC2D57FA8Q46063891-2D1AA5EB-8320-4894-8484-02340FFD0981Q48038040-2035CC70-79E4-4DFA-AE63-3CF643F2DED5Q58599638-AAD36059-62E6-4753-BB07-BD3F641ED906Q58843190-75639DAC-AD3C-4681-BB55-CB9E0AEFE3BC
P2860
A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
A randomized trial of carvedil ...... chronic Chagas cardiomyopathy.
@en
type
label
A randomized trial of carvedil ...... chronic Chagas cardiomyopathy.
@en
prefLabel
A randomized trial of carvedil ...... chronic Chagas cardiomyopathy.
@en
P2093
P1476
A randomized trial of carvedil ...... chronic Chagas cardiomyopathy
@en
P2093
Adelina M Reis
Airandes S Pinto
Antonio L Teixeira
Bráulio M R Oliveira
Cid S Ferreira
Darlington O Okonko
Fernando A Botoni
Jackellyne B P Dantas
Manoel Otávio C Rocha
Mauro M Teixeira
P304
P356
10.1016/J.AHJ.2006.12.017
P407
P577
2007-04-01T00:00:00Z